Sun Pharma Advanced Research Company Ltd vs Trident Lifeline Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Sun Pharma Advanced Research Company Ltd is ₹ 161.6 as of 18 May 14:03 . The P/E Ratio of Sun Pharma Advanced Research Company Ltd changed from -14 on March 2025 to 0 on March 2022 . This represents a CAGR of -100.00% over 2 yearsThe P/E Ratio of Trident Lifeline Ltd changed from 30.4 on March 2023 to 0 on March 2022 . This represents a CAGR of -100.00% over 4 years The Market Cap of Sun Pharma Advanced Research Company Ltd changed from ₹ 5823 crore on March 2023 to ₹ 0 crore on March 2022 . This represents a CAGR of -100.00% over 4 yearsThe Market Cap of Trident Lifeline Ltd changed from ₹ 182.95 crore on March 2023 to ₹ 0 crore on March 2022 . This represents a CAGR of -100.00% over 4 years The revenue of Sun Pharma Advanced Research Company Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 8.45 crore. This represent the decline of -100% The revenue of Trident Lifeline Ltd for the Mar '26 is ₹ 50.26 crore as compare to the Dec '25 revenue of ₹ 30.34 crore. This represent the growth of 65.66% The ebitda of Sun Pharma Advanced Research Company Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ -69 crore. This represent the decline of -100% The ebitda of Trident Lifeline Ltd for the Mar '26 is ₹ 12.91 crore as compare to the Dec '25 ebitda of ₹ 9.72 crore. This represent the growth of 32.82% The net profit of Sun Pharma Advanced Research Company Ltd changed from ₹ -95.9 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The net profit of Trident Lifeline Ltd changed from ₹ 1.6 crore to ₹ 6.87 crore over 8 quarters. This represents a CAGR of 107.21% The Dividend Payout of Sun Pharma Advanced Research Company Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Trident Lifeline Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Sun Pharma Advanced Research Company Ltd

Sun Pharma Advanced Research Company Limited (SPARC) is a clinical stage bio-pharmaceutical company engaged in creating new drugs and delivery systems.
The Company works on innovation and new product development for global markets.
They undertake projects in research and technology for new chemical entities (NCE's) or new molecules, and novel drug delivery systems (NDDS). Sun Pharmaceutical Advanced Research Company Limited was incorporated on March 1, 2006 as an innovative and development company.
It commenced operations on March 22, 2006.
As per Scheme of Arrangement, the entire business undertaking of the Innovative Research & Development including Novel Drug Delivery System (NDDS) Division of Sun Pharmaceuticals Industries' Research & Development Undertaking was transferred and vested into the Company effective from February 28, 2007.

About Trident Lifeline Ltd

Trident Lifeline Limited was originally incorporated as Private Limited Company as 'Trident Lifeline Private Limited' on January 09, 2014.
Subsequently, Company converted into a Public Limited and the name of Company was changed to 'Trident Lifeline Limited' on June 10, 2022.
The Company is engaged in business of marketing ethical pharmaceutical products in domestic as well as international market.
It is also engaged in distribution of pharmaceutical products through third party distribution network. Apart from these, the Company offer wide range of pharmaceutical formulations and products manufactured on contract manufacturing under loan license.
It operate in India as well as African, Latin American and East Indian Countries.

FAQs for the comparison of Sun Pharma Advanced Research Company Ltd and Trident Lifeline Ltd

Which company has a larger market capitalization, Sun Pharma Advanced Research Company Ltd or Trident Lifeline Ltd?

Market cap of Sun Pharma Advanced Research Company Ltd is 5,309 Cr while Market cap of Trident Lifeline Ltd is 302 Cr

What are the key factors driving the stock performance of Sun Pharma Advanced Research Company Ltd and Trident Lifeline Ltd?

The stock performance of Sun Pharma Advanced Research Company Ltd and Trident Lifeline Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Sun Pharma Advanced Research Company Ltd and Trident Lifeline Ltd?

As of May 18, 2026, the Sun Pharma Advanced Research Company Ltd stock price is INR ₹163.6. On the other hand, Trident Lifeline Ltd stock price is INR ₹253.5.

How do dividend payouts of Sun Pharma Advanced Research Company Ltd and Trident Lifeline Ltd compare?

To compare the dividend payouts of Sun Pharma Advanced Research Company Ltd and Trident Lifeline Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.